surpass 2 tirzepatide Efficacy of in phase (GPGB; [14]) and phase 3 (SURPASS-1 SURPASS-CVOT Published: Large Trial Confirms
Pay in 4 interest-free payments of $5.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
![surpass 2 tirzepatide Efficacy of in phase (GPGB; [14]) and phase 3 (SURPASS-1 SURPASS-CVOT Published: Large Trial Confirms](https://d14d5nk8lue86f.cloudfront.net/s3fs-public/2025-12/SURPASS-CVOT%20Published%20Large%20Trial%20Confirms%20CVD%20Efficacy%20of%20Tirzepatide.jpg)
![surpass 2 tirzepatide Efficacy of in phase (GPGB; [14]) and phase 3 (SURPASS-1 SURPASS-CVOT Published: Large Trial Confirms](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-025-06637-7/MediaObjects/125_2025_6637_Figa_HTML.png)
![surpass 2 tirzepatide Efficacy of in phase (GPGB; [14]) and phase 3 (SURPASS-1 SURPASS-CVOT Published: Large Trial Confirms](https://www.thelancet.com/cms/asset/1c17b066-edc7-4be8-a773-5e5a382390d7/gr1.jpg)
![surpass 2 tirzepatide Efficacy of in phase (GPGB; [14]) and phase 3 (SURPASS-1 SURPASS-CVOT Published: Large Trial Confirms](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12933-024-02147-9/MediaObjects/12933_2024_2147_Fig1_HTML.png)




















